retatrutide phase 2 weight loss results π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No plateau β curve still descending Air Mail | On TikTok,
Description
Monitoring may include mood, sleep, anxiety, blood pressure, appetite, side effects, and seizure-risk factors
Stopping a high dose abruptly can cause rebound hunger, rapid weight regain, and blood sugar instability
Some patients may notice increased awareness of breathing during physical activity as they become more active following weight loss
Wegovy 0.5 mg solution for injection in pre-filled pen Summary of Product Characteristics
Chronic-care now contributes 39.3% of its domestic business
2023;14 doi: 10.3389/fimmu.2023.1157537
